1312609-83-8 Usage
Uses
Used in Pharmaceutical Industry:
Ethyl 4-bromo-2,3-dihydroxybenzoate is used as a pharmaceutical intermediate for its potential pharmacological properties. It plays a crucial role in the development of new drugs and medicines, contributing to the advancement of healthcare.
Used in Research Laboratories:
In research laboratories, Ethyl 4-bromo-2,3-dihydroxybenzoate is utilized for its potential pharmacological properties, enabling scientists to study and understand its applications in various fields of research.
Used in Organic Synthesis:
Ethyl 4-bromo-2,3-dihydroxybenzoate is used as an intermediate in the synthesis of various organic compounds. Its unique structure and properties make it a valuable component in the creation of new organic molecules with specific functions and applications.
Used in Chemical Research:
In the field of chemical research, Ethyl 4-bromo-2,3-dihydroxybenzoate is employed to explore its potential applications and properties. Researchers use this compound to investigate its chemical behavior, reactivity, and interactions with other compounds, contributing to the broader understanding of organic chemistry.
Check Digit Verification of cas no
The CAS Registry Mumber 1312609-83-8 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,1,2,6,0 and 9 respectively; the second part has 2 digits, 8 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 1312609-83:
(9*1)+(8*3)+(7*1)+(6*2)+(5*6)+(4*0)+(3*9)+(2*8)+(1*3)=128
128 % 10 = 8
So 1312609-83-8 is a valid CAS Registry Number.
1312609-83-8Relevant articles and documents
NOVEL INHIBITORS OF HEPATITIS C VIRUS REPLICATION
-
, (2011/07/06)
The embodiments provide compounds of the general Formulae I, II, III, IV, or V as well as compositions, including pharmaceutical compositions, comprising a subject compound. The embodiments further provide treatment methods, including methods of treating a hepatitis C virus infection and methods of treating liver fibrosis, the methods generally involving administering to an individual in need thereof an effective amount of a subject compound or composition.